| Total | | Male | | Female | |
Subtable 1 | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P |
Non-HTGW | Reference | | Reference | | Reference | |
HTGW | 2.00 (1.58 to 2.54) | < 0.001 | 1.29 (0.82 to 2.04) | 0.269 | 2.36 (1.77 to 3.15) | < 0.001 |
| Total | | Male | | Female | |
Subtable 2 | β (95% CI) | P | β (95% CI) | P | β (95% CI) | P |
Non-HTGW | Reference | | Reference | | Reference | |
HTGW | 0.36 (0.27 to 0.45) | < 0.001 | 0.26 (0.05 to 0.46) | 0.013 | 0.37 (0.27 to 0.47) | < 0.001 |
- Notes: Non-HTGW includes 3 phenotypes: NTNW normal triglyceride levels and normal waist circumference; NTGW normal triglyceride levels and enlarged waist circumference; HTNW elevated triglyceride levels and normal waist circumference. HTGW elevated triglyceride levels and enlarged waist circumference; OR odds ratio; CI confidence interval
- Subtable 1: The outcome was categorized as hyperuricemia and nonhyperuricemia
- Subtable 2: The outcome was calculated by the level of uric acid
- The model was adjusted for age, education, marital status, residential location, smoking, alcohol consumption, body mass index, and health status